Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 6, 2021
has subject area
- 11 Medical and Health Sciences (FoR)
- Angiotensin II Type 1 Receptor Blockers (MeSH)
- Angiotensin-Converting Enzyme Inhibitors (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Hyperkalemia (MeSH)
- Kidney Diseases (MeSH)
- Mineralocorticoid Receptor Antagonists (MeSH)
- Potassium (MeSH)
- Renin-Angiotensin System (MeSH)
- Risk Factors (MeSH)